Loading...
•
Jun 30, 2020
Globus Medical Q2 2020 Earnings Report
Globus Medical's revenue decreased, resulting in a net loss, but non-GAAP EPS remained positive, and the company focused on strategic improvements during the second quarter.
Key Takeaways
Globus Medical reported a decrease in worldwide sales by 23.4% compared to the second quarter of 2019. The company experienced a net loss of $20.8 million, but non-GAAP diluted EPS was $0.07. Despite the challenges, Globus Medical focused on strengthening its business for future growth.
Worldwide sales decreased by 23.4% year-over-year to $148.9 million.
The company had a net loss of $20.8 million.
Diluted EPS was $(0.21), while non-GAAP diluted EPS was $0.07.
Non-GAAP adjusted EBITDA was 14.7% of sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Revenue by Segment
Musculoskeletal Solutions Revenue
CapyFin.comEnabling Technologies Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Globus Medical withdrew its full year 2020 guidance due to the uncertainties related to the COVID-19 pandemic.
Revenue & Expenses
Visualization of income flow from segment revenue to net income